ICON Plc - Company Profile

All the sales intelligence you need on ICON Plc in one solution.

Save hours of research time with a comprehensive
Sales Intelligence Solution.
Understand how ICON Plc fits into your total
addressable market and Ideal Customer Profile.
Gain competitive edge with triggers that tell you
when and how to engage with ICON Plc.

ICON Plc: Premium Databases

Contact the team or request a demo to find out how our data can drive your business forward

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Headline	Published	Journalists
Showing 3 of 100+ results.
Deserunt mollit sunt Lorem laborum do id aliqua dolore	24 Nov 2022	Lorem
Nectin Therapeutics engages with CRO ICON for Phase I trial of solid tumor candidate	08 Mar 2022	William Newton
Rational Vaccines in CRO talks for Phase I/II therapeutic herpes vaccine trial, ICON is ‘frontrunner’; eyes USD 30–60m Series B by 3Q22	28 Jan 2022	William Newton
Vaxart engaged with CRO Icon for Phase II trial of COVID-19 vaccine tablet	11 Nov 2021	Reynald Castaneda

Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.

Drug Insights:

Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
Material intelligence on competitors, including breaking news
Insight on companies’ business development needs and strategies

Outsourcing Insights:

Insight on companies’ CRO and business development needs, strategies and relationships

Remove risk and uncertainty

Gain a competitive edge

Secure actionable leads

Gain a 360-degree view of ICON Plc and make more informed decisions for your business

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer